[
    [
        {
            "time": "2021-08-XX",
            "original_text": "白雲山上半年净利润增超四成：收入占比最高的商業板块将分拆上市，大健康和大南藥板块何时撑起“半边天”？",
            "features": {
                "keywords": [
                    "白雲山",
                    "净利润",
                    "商业板块",
                    "分拆上市",
                    "大健康",
                    "大南药"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "商业"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "白雲山上半年净利润增超四成：收入占比最高的商業板块将分拆上市，大健康和大南藥板块何时撑起“半边天”？",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-08-XX",
            "original_text": "白雲山公布半年报 上半年净利增加41.84%",
            "features": {
                "keywords": [
                    "白雲山",
                    "半年报",
                    "净利润",
                    "增长"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "白雲山公布半年报 上半年净利增加41.84%",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-08-XX",
            "original_text": "白雲山涨超4% 中期纯利同比增长41.84%",
            "features": {
                "keywords": [
                    "白雲山",
                    "中期纯利",
                    "同比增长"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "白雲山涨超4% 中期纯利同比增长41.84%",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-08-XX",
            "original_text": "港股异动 | 白雲山(0874.HK)涨超5% 中期纯利同比增长41.84%",
            "features": {
                "keywords": [
                    "港股",
                    "白雲山",
                    "中期纯利",
                    "同比增长"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "港股异动 | 白雲山(0874.HK)涨超5% 中期纯利同比增长41.84%",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-08-XX",
            "original_text": "广州白雲山医药集团股份有限公司2021半年度报告摘要",
            "features": {
                "keywords": [
                    "白雲山",
                    "半年度报告",
                    "摘要"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "广州白雲山医药集团股份有限公司2021半年度报告摘要",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 10,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-08-XX",
            "original_text": "港股盘前必读：騰訊控股第二季度净利润425.87亿元同比增29%",
            "features": {
                "keywords": [
                    "港股",
                    "騰訊控股",
                    "净利润",
                    "同比增长"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "科技"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "港股盘前必读：騰訊控股第二季度净利润425.87亿元同比增29%",
                "Correlation": 2,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-08-XX",
            "original_text": "白雲山(00874.HK)中期多赚42% 下半年重点推进六项工作",
            "features": {
                "keywords": [
                    "白雲山",
                    "中期",
                    "净利润",
                    "增长",
                    "下半年",
                    "六项工作"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "白雲山(00874.HK)中期多赚42% 下半年重点推进六项工作",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]